Average Co-Inventor Count = 1.33
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hybridon, Inc. (11 from 98 patents)
2. Children's Medical Center Corporation (2 from 1,036 patents)
3. Other (1 from 832,891 patents)
12 patents:
1. 6649596 - Modified VEGF Oligonucleotides for Inhibition of tumor growth
2. 6410322 - Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
3. 6399586 - Modified VEGF oligonucleotides
4. 6306829 - Modified VEGF oligonucleotides for treatment of skin disorders
5. 5814620 - Inhibition of neovascularization using vegf-specific oligonucleotides
6. 5801156 - Inhibition of neovascularization using VEGF-specific oligonucleotides
7. 5731294 - Inhibition of neovasularization using VEGF-specific oligonucleotides
8. 5710136 - Inhibition of neovascularization using VEGF-specific oligonucleotides
9. 5661135 - Human VEGF-specific oligonucleotides
10. 5641756 - Modified VEGF oligonucleotides
11. 5639736 - Human VEGF-specific oligonucleotides
12. 5639872 - Human VEGF-specific oligonucleotides